Skip to search.
 FTSE 100 Up 0.08%

MannKind Corp. (MNKD)

-NasdaqGM
0.97 Down 0.02(1.92%) 27 May 21:00
Prev Close:0.99
Open:0.99
Bid:0.96 x 100
Ask:1.00 x 500
1y Target Est:1.43
Beta:2.97385
Earnings Date:8 Aug - 12 Aug (Est.)
Day's Range:0.96 - 1.01
52wk Range:0.64 - 7.32
Volume:3,207,407
Avg Vol (3m):6,638,920
Market Cap:463.83m
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MNKD at this time.

Comparison

Symbol% ChgMkt Cap
MNKDDown 1.92%463.83m
LLYDown 0.70%79.13b
GSKDown 0.79%103.84b
NVODown 1.09%141.06b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.24
Quarterly EPS Est (Jun-16) :-0.06
Mean Recommendation*:3.2
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback